Cargando…

The G1 phase optical reporter serves as a sensor of CDK4/6 inhibition in vivo

Visualization of cell-cycle G1 phase for monitoring the early response of cell cycle specific drug remains challenging. In this study, we developed genetically engineered bioluminescent reporters by fusing full-length cyclin E to the C-terminal luciferase (named as CycE-Luc and CycE-Luc2). Next, HeL...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Cuiping, Guo, Yuxian, Liu, Jingjing, Gao, Yiyang, Wei, Min, Zhao, Ruijun, Chen, Min, Zhang, Guojun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7975702/ https://www.ncbi.nlm.nih.gov/pubmed/33767584 http://dx.doi.org/10.7150/ijbs.52101

Ejemplares similares

ERK Hyperactivation Serves as a Unified Mechanism of Escape in Intrinsic and Acquired CDK4/6 Inhibitor Resistance in Acral Lentiginous Melanoma
por: Rebecca, Vito, et al.
Publicado: (2023)

CDK1 serves as a therapeutic target of adrenocortical carcinoma via regulating epithelial–mesenchymal transition, G2/M phase transition, and PANoptosis
por: Ren, Liwen, et al.
Publicado: (2022)

Loss of CDK4/6 activity in S/G2 phase leads to cell cycle reversal
por: Cornwell, James A., et al.
Publicado: (2023)

CDK modulation coordinates G(1) events after S phase
por: Lacefield, Soni
Publicado: (2014)

Pax6 Lengthens G1 Phase and Decreases Oscillating Cdk6 Levels in Murine Embryonic Cortical Progenitors
por: Mi, Da, et al.
Publicado: (2018)

Selectable Ultrasensitive Detection of Hg(2+) with Rhodamine 6G-Modified Nanoporous Gold Optical Sensor
por: Wang, Zheng, et al.
Publicado: (2016)

A Cdk4/6-dependent phosphorylation gradient regulates the early to late G1 phase transition
por: Kaulich, Manuel, et al.
Publicado: (2021)

CDK1 serves as a potential prognostic biomarker and target for lung cancer
por: Li, Mingyao, et al.
Publicado: (2020)

CDK1 serves as a novel therapeutic target for endometrioid endometrial cancer
por: Ying, Xue, et al.
Publicado: (2021)

The interplay of CDK4 and CDK6 in melanoma
por: Kollmann, Karoline, et al.
Publicado: (2019)

Partial inhibition of Cdk1 in G(2) phase overrides the SAC and decouples mitotic events
por: McCloy, Rachael A, et al.
Publicado: (2014)

The transcriptome of CDK4/6 inhibition
por: Knudsen, Erik S., et al.
Publicado: (2017)

Inducible deletion of CDK4 and CDK6 – deciphering CDK4/6 inhibitor effects in the hematopoietic system
por: Maurer, Barbara, et al.
Publicado: (2020)

Molecular and in vivo Functions of the CDK8 and CDK19 Kinase Modules
por: Dannappel, Marius Volker, et al.
Publicado: (2019)

CDK4/6 initiates Rb inactivation and CDK2 activity coordinates cell-cycle commitment and G1/S transition
por: Kim, Sungsoo, et al.
Publicado: (2022)

CENPF/CDK1 signaling pathway enhances the progression of adrenocortical carcinoma by regulating the G2/M-phase cell cycle
por: Huang, Yu-gang, et al.
Publicado: (2022)

NEK2 serves as a prognostic biomarker for hepatocellular carcinoma
por: Li, Gang, et al.
Publicado: (2017)

Unexpected Outcomes of CDK4/6 Inhibition
por: Choi, Yoon Jong, et al.
Publicado: (2013)

The role of CDK6 in cancer
por: Nebenfuehr, Sofie, et al.
Publicado: (2020)

Co-targeting CDK2 and CDK4/6 overcomes resistance to aromatase and CDK4/6 inhibitors in ER+ breast cancer
por: Al-Qasem, Abeer J., et al.
Publicado: (2022)

CDK2AP1 influences immune infiltrates and serves as a prognostic indicator for hepatocellular carcinoma
por: Che, Yibin, et al.
Publicado: (2022)

In vivo visualization of fluorescence reflecting CDK4 activity in a breast cancer mouse model
por: Gao, Yi‐Yang, et al.
Publicado: (2022)

T Cell-Intrinsic CDK6 Is Dispensable for Anti-Viral and Anti-Tumor Responses In Vivo
por: Klein, Klara, et al.
Publicado: (2021)

Bacillus subtilis 6S-2 RNA serves as a template for short transcripts in vivo
por: Hoch, Philipp G., et al.
Publicado: (2016)

SUMOylation of Rb enhances its binding with CDK2 and phosphorylation at early G1 phase
por: Meng, Fengxi, et al.
Publicado: (2016)

Phosphorescent Ir(III) complexes conjugated with oligoarginine peptides serve as optical probes for in vivo microvascular imaging
por: Yasukagawa, Mami, et al.
Publicado: (2021)

CDK-mediated RNF4 phosphorylation regulates homologous recombination in S-phase
por: Luo, Kuntian, et al.
Publicado: (2015)

Targeting G(1)/S phase cell-cycle genomic alterations and accompanying co-alterations with individualized CDK4/6 inhibitor–based regimens
por: Kato, Shumei, et al.
Publicado: (2021)

Molecular mechanism of G(1) arrest and cellular senescence induced by LEE011, a novel CDK4/CDK6 inhibitor, in leukemia cells
por: Tao, Yan-Fang, et al.
Publicado: (2017)

Soft and Stretchable Polymeric Optical Waveguide-Based Sensors for Wearable and Biomedical Applications
por: Guo, Jingjing, et al.
Publicado: (2019)

Distinct CDK6 complexes determine tumor cell response to CDK4/6 inhibitors and degraders
por: Wu, Xuewei, et al.
Publicado: (2021)

CDK6 Immunophenotype Implicates Potential Therapeutic Application of CDK4/6 Inhibitors in Urothelial Carcinoma
por: Sun, Ran, et al.
Publicado: (2022)

Silencing CDK6-AS1 inhibits LPS-induced inflammatory damage in HK-2 cells
por: Wu, Ling, et al.
Publicado: (2021)

Cyclin D/CDK4/6 activity controls G1 length in mammalian cells
por: Dong, Peng, et al.
Publicado: (2018)

CDK4/6 inhibition in luminal breast cancer
por: Gampenrieder, Simon Peter, et al.
Publicado: (2016)

The application and prospect of CDK4/6 inhibitors in malignant solid tumors
por: Du, Qi, et al.
Publicado: (2020)

Concurrent targeting of BMI1 and CDK4/6 abrogates tumor growth in vitro and in vivo
por: Elango, Ramesh, et al.
Publicado: (2019)

Double-negative feedback between S-phase cyclin-CDK and CKI generates abruptness in the G1/S switch
por: Venta, Rainis, et al.
Publicado: (2012)

Selective inhibition of CDK4/6: A safe and effective strategy for developing anticancer drugs
por: Yuan, Kai, et al.
Publicado: (2021)

Combined Inactivation of Pocket Proteins and APC/C(Cdh1) by Cdk4/6 Controls Recovery from DNA Damage in G1 Phase
por: Shaltiel, Indra A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2s4c98tnae7507oe8cbsu9fess